• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-p200 Pemphigoid Mimicking Acquired Reactive Perforating Collagenosis.

作者信息

Fleißner Janik, Ickrath Katrin, Goebeler Matthias, Benoit Sandrine, Kerstan Andreas

机构信息

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

出版信息

Acta Derm Venereol. 2024 Sep 9;104:adv40627. doi: 10.2340/actadv.v104.40627.

DOI:10.2340/actadv.v104.40627
PMID:39248294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403362/
Abstract
摘要

相似文献

1
Anti-p200 Pemphigoid Mimicking Acquired Reactive Perforating Collagenosis.模仿获得性反应性穿通性胶原病的抗p200类天疱疮
Acta Derm Venereol. 2024 Sep 9;104:adv40627. doi: 10.2340/actadv.v104.40627.
2
Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis.二肽基肽酶-4 抑制剂相关性大疱性类天疱疮患者合并获得性反应性穿孔性胶原病。
J Dermatol. 2018 May;45(5):600-602. doi: 10.1111/1346-8138.14254. Epub 2018 Feb 14.
3
[Anti-p200 pemphigoid].[抗p200类天疱疮]
Hautarzt. 2019 Apr;70(4):271-276. doi: 10.1007/s00105-019-4376-x.
4
Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.抗 p200 天疱疮的实验室诊断和临床特征。
JAMA Dermatol. 2016 Aug 1;152(8):897-904. doi: 10.1001/jamadermatol.2016.1099.
5
[Anti-p200 pemphigoid: a spectacular response to dapsone].[抗p200类天疱疮：对氨苯砜的显著反应]
Ann Dermatol Venereol. 2011 Nov;138(11):739-42. doi: 10.1016/j.annder.2011.05.024. Epub 2011 Jul 22.
6
A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.获得性反应性穿通性皮病样大疱性类天疱疮的一种新临床变体。
Br J Dermatol. 2019 Jan;180(1):231-232. doi: 10.1111/bjd.17146. Epub 2018 Nov 13.
7
Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.一名大疱性类天疱疮患者对奥马珠单抗的生物学和临床反应
Acta Derm Venereol. 2018 Feb 7;98(2):284-286. doi: 10.2340/00015555-2845.
8
[Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].[抗p200类天疱疮：霉酚酸酯（骁悉®）治疗下的缓解]
Ann Dermatol Venereol. 2013 Dec;140(12):784-7. doi: 10.1016/j.annder.2013.07.005. Epub 2013 Aug 13.
9
A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.一例抗层粘连蛋白 γ1（p200）天疱疮在二肽基肽酶-4 抑制剂治疗后发生。
J Dermatol. 2024 Jun;51(6):869-872. doi: 10.1111/1346-8138.17105. Epub 2024 Jan 12.
10
Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.一种简单免疫组织化学染色技术在鉴别抗p200类天疱疮与其他自身免疫性水疱病中的应用：2例报告
Actas Dermosifiliogr. 2017 Jan-Feb;108(1):e1-e5. doi: 10.1016/j.ad.2015.10.019. Epub 2016 Apr 16.

引用本文的文献

1
Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical-Laboratory Experience of a Single Central European Reference Centre.类天疱疮疾病中抗层粘连蛋白β4抗体：一个中欧单一参考中心的临床实验室经验
Antibodies (Basel). 2025 Aug 1;14(3):66. doi: 10.3390/antib14030066.

本文引用的文献

1
Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit.基于重组层粘连蛋白β4亚基的抗p200类天疱疮血清学诊断的灵敏且特异检测方法。
Br J Dermatol. 2024 Jun 20;191(1):140-141. doi: 10.1093/bjd/ljae136.
2
Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid.层粘连蛋白 β4 是皮肤基底膜带的组成部分，也是抗 p200 类天疱疮的另一种自身抗原。
J Am Acad Dermatol. 2024 Apr;90(4):790-797. doi: 10.1016/j.jaad.2023.11.014. Epub 2023 Nov 20.
3
Anti-p200 pemphigoid mimicking erythema multiforme.
模仿多形红斑的抗p200类天疱疮
JAAD Case Rep. 2022 Jan 22;21:157-159. doi: 10.1016/j.jdcr.2022.01.011. eCollection 2022 Mar.
4
Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases.2016 年德国北部天疱疮类疾病的发病率——来自石勒苏益格-荷尔斯泰因自身免疫性大疱性疾病登记处的首批数据。
J Eur Acad Dermatol Venereol. 2021 May;35(5):1197-1202. doi: 10.1111/jdv.17107. Epub 2021 Feb 10.
5
Case of anti-laminin γ1 pemphigoid associated with ulcerative colitis and acquired perforating dermatosis.抗层粘连蛋白γ1型类天疱疮合并溃疡性结肠炎及获得性穿通性皮肤病病例
J Dermatol. 2021 Jan;48(1):e35-e36. doi: 10.1111/1346-8138.15624. Epub 2020 Sep 27.
6
Anti-p200 Pemphigoid: A Systematic Review.抗 p200 天疱疮：系统评价。
Front Immunol. 2019 Oct 22;10:2466. doi: 10.3389/fimmu.2019.02466. eCollection 2019.
7
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.二肽基肽酶-4 抑制剂相关性大疱性类天疱疮。
Front Immunol. 2019 Jun 4;10:1238. doi: 10.3389/fimmu.2019.01238. eCollection 2019.
8
A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.获得性反应性穿通性皮病样大疱性类天疱疮的一种新临床变体。
Br J Dermatol. 2019 Jan;180(1):231-232. doi: 10.1111/bjd.17146. Epub 2018 Nov 13.
9
Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis.二肽基肽酶-4 抑制剂相关性大疱性类天疱疮患者合并获得性反应性穿孔性胶原病。
J Dermatol. 2018 May;45(5):600-602. doi: 10.1111/1346-8138.14254. Epub 2018 Feb 14.
10
Bullous pemphigoid arising in a patient with acquired perforating dermatosis.
Clin Exp Dermatol. 2017 Jun;42(4):406-409. doi: 10.1111/ced.13080. Epub 2017 Feb 20.